Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.19 is 53% below its 5-year average of 4.71, near the low end of its 5-year range (2.19–7.56).
As of the fiscal period ended Tuesday, June 30, 2026. 44.28% below its 12-month average of 3.93.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.19.
QUICK RATIO (ACID-TEST)
2.19
QUICK RATIO (ACID-TEST) AVG TTM
3.93
QUICK RATIO (ACID-TEST) AVG 3Y
4.39
QUICK RATIO (ACID-TEST) AVG 5Y
4.71
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-44.28%
CURRENT VS 3Y AVG
-50.06%
CURRENT VS 5Y AVG
-53.43%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 497 covered companies
CURRENT VS SECTOR MEDIAN
-26.69%
vs the sector median at left
Aligos Therapeutics, Inc.
Market Cap
$33.42M
Quick Ratio (Acid-Test)
2.19
TTM Avg
3.93
3Y Avg
4.39
5Y Avg
4.71
Market Cap
$33.52M
Quick Ratio (Acid-Test)
11.47
TTM Avg
9.93
3Y Avg
10.68
5Y Avg
16.03
Market Cap
$32.32M
Quick Ratio (Acid-Test)
0.70
TTM Avg
2.07
3Y Avg
2.92
5Y Avg
4.15
Market Cap
$32.31M
Quick Ratio (Acid-Test)
0.18
TTM Avg
0.16
3Y Avg
0.31
5Y Avg
0.42
Market Cap
$31.36M
Quick Ratio (Acid-Test)
1.26
TTM Avg
1.70
3Y Avg
1.87
5Y Avg
1.80
Market Cap
$35.89M
Quick Ratio (Acid-Test)
0.74
TTM Avg
0.82
3Y Avg
0.89
5Y Avg
0.96
Market Cap
$30.92M
Quick Ratio (Acid-Test)
5.81
TTM Avg
22.07
3Y Avg
14.94
5Y Avg
12.78
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | $33.42M | 2.19 | 3.93 | 4.39 | 4.71 |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.52M | 11.47 | 9.93 | 10.68 | 16.03 |
| BeyondSpring Inc. (BYSI)vs › | $32.32M | 0.70 | 2.07 | 2.92 | 4.15 |
| EUDA Health Holdings Limited (EUDA)vs › | $32.31M | 0.18 | 0.16 | 0.31 | 0.42 |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | 1.26 | 1.70 | 1.87 | 1.80 |
| Accuray Incorporated (ARAY)vs › | $35.89M | 0.74 | 0.82 | 0.89 | 0.96 |
| Context Therapeutics Inc. (CNTX)vs › | $30.92M | 5.81 | 22.07 | 14.94 | 12.78 |
| DocGo Inc. (DCGO)vs › | $36.05M | 1.66 | 2.38 | 2.35 | 2.72 |
| CervoMed Inc. (CRVO)vs › | $30.65M | 8.57 | 7.97 | 5.03 | 6.79 |
| HeartBeam, Inc. (BEAT)vs › | $36.31M | 3.61 | 1.56 | 4.91 | 7.24 |
Quick Ratio
2.19
Excludes inventory
Current Ratio
2.19
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.19 |
| 2026-03-31 | 2.56 |
| 2025-12-31 | 3.90 |
| 2025-09-30 | 4.70 |
| 2025-06-30 | 6.31 |
| 2025-03-31 | 7.56 |
| 2024-12-31 | 2.86 |
| 2024-09-30 | 3.81 |
| 2024-06-30 | 4.23 |
| 2024-03-31 | 6.25 |
| 2023-12-31 | 5.90 |
| 2023-09-30 | 3.32 |
| 2023-06-30 | 3.46 |
| 2023-03-31 | 3.90 |
| 2022-12-31 | 4.03 |
| 2022-09-30 | 4.91 |
| 2022-06-30 | 5.30 |
| 2022-03-31 | 4.72 |
| 2021-12-31 | 5.25 |
| 2021-09-30 | 7.15 |
| 2021-06-30 | 6.53 |
| 2021-03-31 | 8.71 |
| 2020-12-31 | 8.26 |
| 2020-09-30 | 3.69 |
| 2020-06-30 | 8.61 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 8.70 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
